|
Indian pharma prioritizes skilled workforce proficient in techy & regulatory compliance to meet evolving market needs
|
|
Nandita Vijayasimha, Bengaluru
April 01 , 2025
|
|
|
Indian pharmaceutical sector demands a highly skilled workforce proficient in technology, data science, and regulatory compliance. This is because as the global pharma and life sciences landscape evolves rapidly, hiring trends and talent retention strategies have emerged as key priorities.
With India’s reputation as the ‘pharmacy of the world’ and its growing focus on quality and innovation, companies are rethinking their talent acquisition strategies. The need for specialized professionals is not only driven by operational demands but by the requirement to integrate advanced technologies such as AI, machine learning, and digital platforms into drug discovery and manufacturing, stated Manmeet Singh, CEO - FirstMeridian Global Services and Innovsource.
While fiscal measures like a modest 10% increase in healthcare allocation, amounting to around Rs. 99,858 crore provide a supportive financial backdrop, the emphasis is shifting toward ensuring that the workforce is agile, digitally savvy, and capable of meeting stringent regulatory standards. Indian companies are emphasizing on recruiting professionals with expertise in regulatory compliance, quality control, and advanced manufacturing processes. This is essential to maintain the high quality of drugs manufactured for global markets and to counteract reputational risks from quality lapses, he said.
Building on this strategic financial and operational shift, India’s robust pharmaceutical infrastructure has led to the emergence of new profiles and roles. In major hubs like Delhi, Bengaluru and Hyderabad, the demand is intensifying for talent that can manage the integration of digital tools into healthcare operations. Companies are now focusing on hiring healthcare technologists, data analysts, and regulatory affairs experts who can streamline compliance, foster innovation, and ultimately enhance patient care, he added.
In parallel, the industry faces challenges in hiring and retaining this specialized talent. The fast pace of technological change, evolving regulatory requirements, and increased competition have created a talent gap. The strain on the current workforce has resulted in longer shifts and heightened stress, leading to concerns about burnout and attrition. Addressing these issues calls for comprehensive talent strategies that include improved recruitment practices, robust upskilling programs, and enhanced employee engagement initiatives, Singh told Pharmabiz in an email.
Moreover, as pharma companies strive to meet global regulatory standards, there is an increasing need to recruit individuals with deep expertise in quality control and regulatory compliance. Therefore, companies are investing in continuous training and development programmes to ensure their workforce remains proficient in the latest manufacturing practices and international guidelines, he said.
A strategic push toward investments in technology alongside modest fiscal incentives supports the adoption of advanced analytics, AI, and machine learning. This is driving the evolution of talent profiles. These technologies not only enhance operational efficiency but also enable companies to better predict workforce needs and identify potential skills gaps. In turn, proactive recruitment and targeted training programs can help create a more resilient, future-ready workforce, he noted.
An area of contention is the absence of a major announcement on public-private partnerships and introducing methods that would strengthen medical education in tier 2 and 3 regions that are ridden with lack of financial aid to support aspiring medical students and a qualified set of medical educators. This gap will further intensify the country’s effort to expand healthcare accessibility in non-tier 1 regions and impact people from economically weaker backgrounds. Additionally, the absence of skilling programs for medical and non-medical staff should have been addressed as it can pose a challenge in generating employment in newly established healthcare facilities, said Singh.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|